СÀ¶¾ãÀÖ²¿

09-Oct-2008
Collaborator Release

CLC bio Signs Strategic Collaborative Agreement with СÀ¶¾ãÀÖ²¿

Cambridge, Massachusetts, USA — October 7, 2008 — CLC bio, a world leading full-service bioinformatics solution provider announced today an agreement with the СÀ¶¾ãÀÖ²¿, a not-for profit genomic-focused research institute. The accord consists of a multi-year site license for the entire CLC bio bioinformatics suite of products. The goal is to implement CLC bio's enterprise solution as a scientific platform across all СÀ¶¾ãÀÖ²¿sites. This enterprise solution will provide different research projects at СÀ¶¾ãÀÖ²¿with a coherent integration layer and a standardized way of developing custom software and specialized algorithms.

According to Granger Sutton, Senior Director of Informatics, "СÀ¶¾ãÀÖ²¿will benefit from implementing this enterprise solution, as it is a full enterprise platform that integrates, supports, and enhances workflows across different technologies and geographical sites. The CLC bio software platform impressed our evaluators with its advanced features and intuitive, user-friendly interface."

"We're proud to announce this strategic partnership with JCVI, a leader in genomic research," says CLC bio's North America CEO Jan Lomholdt. "This site license agreement represents another stamp of approval of CLC bio's solution by a globally recognized institution in the scientific community. This partnership will lead to magnificent accomplishments in the scientific arena," Lomholdt adds.   

The enterprise solution CLC bio will be implementing at СÀ¶¾ãÀÖ²¿contains both server structure and support for all major database formats. This ensures a smart and efficient solution for sharing centralized bioinformatics data in a client/server architecture, where the server contains one or more databases and the clients are CLC bio's workbenches.

CLC Bio's solution is a technological gateway that efficiently accesses all data and analysis in a single platform. With CLC bio's enterprise solution all proprietary algorithms and solutions developed at СÀ¶¾ãÀÖ²¿can be accessed from the same bioinformatics platform, ensuring a streamlined workflow with minimal overhead and no tedious time-wasting procedures. CLC bio's developer kit will enable СÀ¶¾ãÀÖ²¿to build targeted plug-ins for their internal use, while allowing СÀ¶¾ãÀÖ²¿to interact based on the same platform with worldwide collaborators. 

СÀ¶¾ãÀÖ²¿ CLC bio

Contact

For further information, please contact:
Jan Lomholdt
CEO, CLC bio North America
Cell phone: +1 (609) 216 3248
E-mail: jlomholdt@clcbio.com